Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access
Cancer screening can save lives and reduce the burden of cancer. However, gaps in cancer screening mean too many in the United States are unnecessarily enduring aggressive treatment or dying from cancers that could have been prevented or detected at earlier, more easily treated stages. This includes disproportionate numbers of socially and economically disadvantaged populations and many at elevated risk for cancer due to inherited mutations in cancer susceptibility genes. In this report, the Panel identifies recommendations to achieve four critical goals for connecting people, communities, and systems to improve equity and access in cancer screening.
Companion Briefs
The Panel highlights issues and recommendations relevant to specific cancer types:
Explore the Cancer Screening Report
-
Letter to President Biden
The President's Cancer Panel letter to President Biden.
-
Executive Summary: Closing Gaps in Cancer Screening
This report presents goals and recommendations to close gaps in cancer screening uptake.
-
Part 1 - Cancer Screening in the United States: Challenges and Opportunities
Cancer screening reduces the burden of cancer. Barriers to screening must be addressed to optimize benefits.
-
Part 2 - Taking Action to Close Gaps in Cancer Screening
The Panel identifies four critical goals to improve equity in and access to cancer screening.
-
Part 3 - Conclusions
The Panel urges all stakeholders to work together to close gaps in cancer screening.
-
Acknowledgments
The Panel appreciates those who contributed to the meeting series and resulting report.
-
President’s Cancer Panel Goals and Recommendations
Recommendations from the President's Cancer Panel to optimize cancer screening in the United States.
-
About the Panel Members
The following members of the President’s Cancer Panel planned and executed a series of workshops in 2020–2021 on cancer screening. In February 2022, a report was submitted to the White House with findings and recommendations to promote equity in and access to cancer screening.